- Home
- PCVX vs SKT Comparison
PCVX vs SKT Comparison
Compare PCVX & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | SKT |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 3.9B |
| IPO Year | 2020 | 1993 |
Fundamental Metrics
Financial Performance| Metric | PCVX | SKT |
|---|---|---|
| Price | $46.76 | $32.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $101.67 | $36.13 |
| AVG Volume (30 Days) | ★ 1.5M | 641.8K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | N/A | ★ 8.00 |
| EPS | N/A | ★ 0.94 |
| Revenue | N/A | ★ $575,140,000.00 |
| Revenue This Year | N/A | $2.91 |
| Revenue Next Year | N/A | $4.62 |
| P/E Ratio | ★ N/A | $34.15 |
| Revenue Growth | N/A | ★ 10.01 |
| 52 Week Low | $27.66 | $28.69 |
| 52 Week High | $94.60 | $36.76 |
Technical Indicators
Market Signals| Indicator | PCVX | SKT |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 37.12 |
| Support Level | $43.78 | $32.43 |
| Resistance Level | $48.11 | $33.79 |
| Average True Range (ATR) | 1.99 | 0.66 |
| MACD | -0.49 | -0.16 |
| Stochastic Oscillator | 42.99 | 10.82 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.